肥胖的药理学中的类悖论
Sanjay Kalra1, Amandeep Singh2, Nitin Kapoor3
1Department of Endocrinology, Bharti Hospital, Karnal, India; University Center for Research & Development, Chandigarh University, Mohali, India.
JPMA. The Journal of the Pakistan Medical Association
|August 2, 2025
概括
肥胖治疗中的类药理学提出了独特的挑战. 了解因药物特性而产生的悖论,对于临床医生来说是优化患者治疗结果的关键.
科学领域:
- 体生物学和药理学 体生物学和药理学
- 内分泌学和代谢研究.
背景情况:
- 类蛋白作为体内的激素和代谢调节器起着至关重要的作用.
- 的临床应用,特别是在肥胖管理中,是复杂的.
- 类药物的某些特征可能导致意想不到或矛盾的效果.
研究的目的:
- 阐明与肥胖中的类药理学相关的矛盾结果.
- 提高临床医生对类药物机制和临床变异性的理解.
主要方法:
- 对类药理学和肥胖治疗现有文献的审查.
- 分析常用治疗药物的药理动力学和运动性质.
- 临床病例研究分析 (隐含).
主要成果:
- 确定了有助于产生矛盾效应的特定药理动力学和运动性质.
- 证明了这些悖论如何影响类药物的临床作用.
- 突出了患者对基于的肥胖治疗反应的变化.
结论:
- 对类悖论的认识对于肥胖管理中的有效临床实践至关重要.
- 了解这些悖论有助于选择适当的疗法和管理患者的期望.
- 对性质的进一步研究可能会导致更可预测的治疗结果.
相关概念视频
Regulation of Food Intake
450
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
450
Glucagon-like Receptor Agonists
419
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
419
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
cAMP-dependent Protein Kinase Pathways
6.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
Obesity
615
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
615
Hormonal Regulation
44.4K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
44.4K


